September 11, 2025
The Patent Trial and Appeal Board has agreed to institute review of a patent covering Nike Inc.'s Flyknit line of sneakers, after the acting head of the U.S. Patent and Trademark Office revived Skechers' challenge to the patent.
August 25, 2025
Acting U.S. Patent and Trademark Office Director Coke Morgan Stewart freed WSOU Investments and Nutanix from challenges where the Patent Trial and Appeal Board had already instituted review, but then revived an inter partes review Nike had originally dodged.
June 11, 2025
The Patent Trial and Appeal Board has invoked its discretion to free Nike Inc. and Cleveland Medical Devices from having their patents scrutinized, but refused to do so for Vermeer Manufacturing Co.